A session at the AHA Scientific Sessions 2025 focused on clinical trials related to cutting edge valve and coronary care.
In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD) ...
A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering ...
Chronic kidney disease (CKD) is on the rise in the United States, with roughly 36 million adults estimated to have the ...
Spurred by a positive clinical trial readout recently, Xeltis has raised €47.5m ($55.1m) to advance commercialisation efforts ...
The U.S. Food and Drug Administration (FDA) last year approved of ultrasound and radiofrequency ablation-based renal denervation devices that can be used to “reduce blood pressure as an adjunctive ...
A shared love for the song "Sow Mercy" led to a remarkable kidney transplant story in North Carolina, in which two men ...
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Khraisat, MD, an interventional cardiologist at Aurora Health Care in Milwaukee, Wisconsin, specializes in endovascular ...
Do’s and Dont's in Your First Five Years Out to Advance Your Career Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback